Exelixis (NASDAQ: EXEL) reported Q2 EPS of $0.75, $0.11 better than the analyst estimate of $0.64. Revenue for the quarter came in at $568.3 million versus the consensus estimate of $578.46 million.

GUIDANCE:

Exelixis sees FY2025 revenue of $2.25-2.35 billion, versus the consensus of $2.341 billion.

For earnings history and earnings-related data on Exelixis (EXEL) click here.